Patient Monitors (ICU)

Nihon Kohden is a global medical device manufacturer headquartered in Japan with US operations in Irvine, California. The company specializes in interconnected clinical solutions spanning patient monitoring, ventilation, neurology diagnostics, and sleep medicine across the continuum of care—from ICU and critical care settings to perioperative environments, neurology labs, and sleep centers. Key product lines include the Life Scope® G5 bedside monitor (multiparameter monitoring with iNIBP, arrhythmia detection, QTc/QRSd analysis, and Smart Cable™ technology for parameter expansion); the NKV-550 ventilator system (supporting neonatal through adult patients with invasive/non-invasive ventilation and high-flow oxygen therapy, featuring Protective Control® and Gentle Lung® Suite); the AirEEG® wireless EEG system (clinical-grade wireless recording with 4,000 Hz sampling, automatic location detection, and dual-video review); and AlarmSense™ software (clinical analytics for alarm management with 90-day trend analysis and alarm modeling). Nihon Kohden emphasizes integrated data workflows, transport continuity during intra-hospital patient movement, and real-time clinical decision support. The company targets hospital systems across critical care, perioperative/surgical care, neurology, and sleep diagnostics. Products incorporate advanced monitoring parameters, wireless technology, and connectivity for seamless clinical documentation and team collaboration. The company maintains active engagement with major professional societies including SCCM, HIMSS, ASA, AARC, and AES, reflecting commitment to critical care, anesthesia, respiratory therapy, and neurology specialties. Regulatory compliance and clinical integration capabilities are core to the product portfolio.

Deltex Medical is a global leader in haemodynamic monitoring technology, specializing in oesophageal Doppler monitoring (ODM) systems. The company manufactures the TrueVue™ advanced haemodynamic monitoring platform, designed to provide real-time, precise patient haemodynamic data for use in surgical and critical care settings. The TrueVue™ system features enhanced ODM signal acquisition, intuitive HD touchscreen controls, integrated battery for portability, and user-centric design to support clinicians across varied clinical environments. The technology is clinically proven to help reduce avoidable complications including acute kidney injury, acute respiratory distress syndrome, and surgical site infections. Deltex Medical serves anaesthetists and critical care specialists globally, with manufacturing and regulatory operations based in the United Kingdom. The company offers eLearning and training resources through its dedicated education platform, and maintains customer support through regional enquiry lines and service channels.

Integra LifeSciences Corporation is a global medical technology company specializing in surgical, neurologic, and regenerative care products. The company manufactures and distributes a comprehensive portfolio spanning neurosurgery (dural repair, cranial reconstruction, hydrocephalus management, CSF drainage systems, multimodal neuro-critical care monitoring), wound reconstruction and care (engineered collagen, fetal bovine dermis, urinary bladder matrix, amniotic tissue, Manuka honey dressings, total contact casting), surgical reconstruction (nerve and tendon repair, hernia repair, plastic and reconstructive surgery), surgical instrumentation and lighting (including brands Jarit®, MicroFrance®, Omni-Tract®, Ruggles®-Redmond™, Padgett®, and Miltex®), and ear, nose and throat devices (airway dilation systems, balloon sinuplasty, nasal dilation, Eustachian tube dilation, navigation systems). The company serves hospitals, surgery centers, and tissue banks globally. Integra maintains extensive international operations with customer service, repair, and medical inquiry support across North America, Europe, Asia-Pacific, and other regions. The company provides clinical documentation, IFUs (Instructions for Use), and regulatory support resources on its products portal.

ICU Medical, Inc. is a critical care medical device manufacturer specializing in infusion therapy, airway management, hemodynamic monitoring, and related ICU solutions. The company designs and manufactures a comprehensive portfolio of products spanning IV catheters, infusion pumps (Plum Duo™ and Plum Solo™ precision IV pumps), needlefree IV connectors (Clave™ portfolio), pharmacy preparation automation, closed-system transfer devices, IV safety software (LifeShield™), tracheostomy tubes, breathing support equipment, temperature management devices (fluid warmers and temperature probes), hemodialysis catheters, regional anesthesia trays, and pain management tools. ICU Medical recently launched the IV Performance Platform, a fully EHR-interoperable system integrating precision pumps with digital safety software to standardize IV therapy workflows and reduce infection risk. The company has established a joint venture with Otsuka Pharmaceutical Factory to manufacture IV solutions, representing combined annual production capacity exceeding 1.4 billion units. Products carry FDA 510(k) clearances; recent clearances include new labeling claims for Clave needlefree connectors supported by peer-reviewed infection reduction data. The company serves acute care hospitals, ICUs, operating rooms, and perioperative settings. ICU Medical emphasizes workflow simplification, patient safety, and clinical standardization without compromising care quality.

Caregility Corporation is an enterprise telehealth and virtual care platform provider serving healthcare systems, hospitals, and care facilities across inpatient, outpatient, and home settings. Founded in 2011, the company delivers the Caregility Connected Care™ Platform, a cloud-based ecosystem that integrates AI-powered clinical workflows, virtual nursing, bedside sensors, and secure video collaboration tools. The platform enables virtual care delivery across emergency departments, ICUs, operating rooms, observation units, behavioral health, neonatal care, and long-term care environments. With deployments in over 1,100 hospitals across 85+ health systems, Caregility facilitates more than 6 million virtual sessions annually. The platform addresses critical healthcare challenges including clinician shortages, geographic access barriers, and operational inefficiency through features such as real-time clinical collaboration, remote patient monitoring, automated workflow support, and integrated analytics. Caregility emphasizes 99.99% platform availability, HIPAA compliance, ISO 27001/27701 certification, and 24/7 expert support, positioning itself as a mission-critical infrastructure provider for hospital networks seeking to scale virtual care at enterprise scale.

Cloudphysician is an AI-driven healthcare technology company providing AI-powered Smart-ICU solutions and virtual critical care services. Founded in 2017 by critical care physicians, the company operates the proprietary RADAR platform—an ambient intelligence system integrating high-definition video, computer vision, AI analytics, and electronic medical record data to enable 24/7 remote ICU monitoring and clinical decision support. The platform detects and prevents adverse events including inpatient falls, pressure ulcers, central line infections, and catheter-associated UTIs, reducing hospital-acquired complications and associated costs. Cloudphysician has deployed solutions across 280+ hospitals managing 2,000+ ICU beds across 22 Indian states, serving 130,000+ patients. The company offers disease-specific AI agents, real-time video analysis, virtual nursing capabilities, and Smart-ICU in a Box solutions optimized for both urban and rural healthcare settings. Its hardware-agnostic architecture integrates seamlessly with existing hospital infrastructure (monitors, cameras, tablets) without requiring device upgrades. The platform operates securely on-premise or in cloud environments with full HIPAA, SOC 2, and ISO 27001 compliance, ensuring patient data remains within hospital environments with no external data transfer.

Veris Health is a digital health platform specializing in personalized cancer care through remote patient monitoring and clinical connectivity. As a majority-owned subsidiary of PAVmed Inc., the company delivers the Veris Cancer Care Platform—a cloud-based solution enabling continuous bidirectional communication between patients and oncology care teams. The platform integrates physiological data collection via VerisBox™ connected devices, symptom tracking, secure messaging, and scheduled video consultations with EHR interoperability. Features include real-time trend analysis, quality-of-life assessments using EQ-5D™, automated reimbursement documentation, and family/caregiver engagement tools. Available on iOS and Android with Spanish-language support. The platform is HIPAA and SOC compliant and aligns with value-based care models including CMS's Enhancing Oncology Model (EOM). Designed for oncology practices, hospital systems, and cancer centers seeking to improve patient engagement and clinical outcomes through remote monitoring.

BioSignal is a neurodiagnostic company specializing in functional brain assessment via portable EEG technology. The company's FDA-approved microEEG® solution is a miniature, wireless clinical platform enabling rapid electroencephalogram (EEG) recording with cloud-based remote interpretation. BioSignal serves traditional neurology settings (epilepsy centers, sleep labs, neurology departments, ICUs) and expands brain function assessment into novel environments including emergency departments, NICUs, physician offices, ambulances, and home care. The platform supports sports concussion management, traumatic brain injury assessment, routine EEG monitoring, and STAT EEG capabilities. Applications span clinical neurology, emergency medicine, pediatric critical care, sleep medicine, sports medicine, and home sleep monitoring. The solution combines hardware portability with interpretive software to enable rapid assessment and telemedicine-capable EEG interpretation.

HEMEDEX INC., founded in 2000, commercializes proprietary MIT-derived technology for real-time quantification of tissue perfusion and cerebral blood flow (CBF) at the capillary level. The company's patented thermal diffusion microprobe-based platform is designed for use in neurocritical care and neurosurgical settings, providing clinicians with continuous, absolute measurements of cerebral perfusion during complex procedures involving compromised vasculature, traumatic brain injury, subarachnoid hemorrhage, and other acute neurological conditions. The Bowman Perfusion Monitor enables bedside multimodal neuromonitoring for up to ten days, offering early warning of tissue ischemia and rapid assessment of intervention efficacy. ISO 13485:2012 certified medical device manufacturer serving leading academic medical centers and neuro ICUs across North America.

Maguire Enterprises is a medical device interconnection specialist with over 50 years of experience integrating physiologic monitoring and life support equipment across thousands of U.S. hospitals. The company designs and manufactures cables, adapters, multipliers, and integrated solutions that enable seamless compatibility between devices from different manufacturers—particularly for critical care environments such as operating rooms, hybrid ORs, catheterization labs, and ICUs. Core offerings include interconnect cables for ECG and invasive blood pressure (IBP) signal transmission, output multipliers for anesthesia monitors and defibrillators, Device Alarm Nurse Call (DANCE) cables for remote alarm monitoring, and cardiac rhythm management adapters for pacemaker programmers and defibrillators. FDA-regulated, with rapid fulfillment capabilities and deep OEM relationships, Maguire solves interoperability challenges that hospitals and device manufacturers face when deploying multi-vendor monitoring ecosystems.

Epitel, Inc. is a digital health company based in Salt Lake City, Utah, specializing in innovative wearable EEG monitoring technology for brain health. Founded in 2008, Epitel developed the REMI™ Remote EEG Monitoring System, an FDA-cleared (2021) wireless, wearable sensor platform designed for seizure detection and electrographic monitoring in both hospital and ambulatory settings. The system features single-channel, high-fidelity EEG recordings with rapid setup (minutes), wireless operation enabling patient mobility, and integration with standard EEG review platforms like Persyst™ Mobile for remote clinician review. REMI Vigilenz™ AI for Event Detection augments clinical review by automatically identifying potential electrographic seizure activity with confidence scoring. The platform is clinically validated, reimbursable under existing codes, and suitable for adult and pediatric patients (1+ years for monitoring; 6+ years for AI analysis). Epitel's technology addresses critical care, emergency department, and outpatient epilepsy monitoring needs. The company has secured over $20 million in funding and brings extensive expertise in medical device development, neural engineering, and regulatory affairs.

Susquehanna Micro Inc. is a Pennsylvania-based medical device distributor and authorized North American dealer for Acutronic high-frequency jet ventilators. The company specializes in the sales, service, and repair of respiratory and pulmonary function testing equipment, serving hospitals, ICUs, family practices, and sports rehabilitation centers. With over 20 years of experience, Susquehanna Micro offers comprehensive respiratory care solutions including ventilation systems (Monsoon III, LSP Autovent), pulmonary function testing equipment from CosMed, metabolic testing systems, patient monitoring devices (oximeters from Masimo, Nonin, Venni), airway management tools (InfantView neonatal video-intubation device), and oxygen delivery accessories. The company partners with leading manufacturers such as Acutronic, CosMed, BioMed Devices, Precision Medical, NDD, and uVida. Susquehanna Micro provides 24/7 emergency service support for ventilators and life support equipment throughout North America. As a veteran and female-owned corporation, the company emphasizes unmatched service, calibration, maintenance, and repair support for critical respiratory care infrastructure.

Videra Health is an AI-powered behavioral health technology platform that automates clinical documentation, remote patient monitoring, and clinical decision support through multimodal analysis of video, audio, and text data. Founded in 2019 and based in Orem, Utah, the company serves 300+ behavioral health facilities with 1M+ patient interactions. The platform features automated patient intake, AI-generated clinical summaries (Sidekick Notes), real-time emotional and risk analysis, and 24/7 patient engagement across multiple channels (video, voice, chat, SMS). Key capabilities include suicide risk detection, tardive dyskinesia screening, and group therapy documentation. Videra's system delivers measurable operational outcomes: 2+ clinician hours reclaimed daily, 85% faster patient engagement, and 64% reduction in crisis interventions. HIPAA and SOC 2 Type II compliant, FDA-registered, and designed specifically for behavioral health workflows in value-based care models.

CEIBA Health Technologies is an AI-powered healthcare technology platform specializing in virtual clinical care and medical device connectivity solutions. The company delivers an integrated Enterprise Suite with four core capabilities: (1) IoMT Interoperability—featuring a plug-and-play IoMT Box with 1,000+ pre-installed device drivers supporting 20+ EHR integrations; (2) Continuous Monitoring—delivering real-time telemetry dashboards for patient monitors, ventilators, infusion pumps, blood gas analyzers, and EEG machines across ICU, med-surge, LTACH, and SNF settings; (3) Decision Support & Workflow—providing actionable clinical insights and operational dashboards; and (4) Virtual Clinical Care—a telehealth platform enabling multi-specialty consultations, remote rounding, and acute care at home. CEIBA's protocol-agnostic architecture supports HL7, FHIR, JSON, and XML with enterprise-grade security, encrypted data transfer, and full mobile functionality. The platform is designed for rapid deployment (days vs. months) and serves hospitals and health systems in the US and internationally.

ViOptix is the recognized leader in real-time tissue oxygenation monitoring, developing the proprietary T.Ox Tissue Oximetry technology. This breakthrough platform enables non-invasive, direct measurement of local tissue oxygen saturation (StO2) in real-time, allowing clinicians to assess tissue health and viability immediately. The Intra.Ox system provides intraoperative and postoperative tissue oxygen monitoring with applications across plastic surgery, reconstructive procedures, peripheral vascular disease assessment, wound healing evaluation, and critical care settings. ViOptix's sensor-based technology delivers accurate perfusion assessment data, helping surgeons make informed decisions about tissue viability and surgical outcomes, with strong clinical validation supporting its use as a standard-of-care tool at leading hospitals.

brain4care is a medical technology company specializing in non-invasive monitoring of intracranial pressure (ICP) and brain dynamics. The company develops portable, wireless sensors and cloud-based algorithms that enable real-time assessment of ICP variation, intracranial compliance progression, and early detection of intracranial hypertension risk without radiation or invasive procedures. The b4c system is FDA 510(k) cleared and Anvisa certified, designed for deployment in ICU settings, critical care units, and outpatient clinics. The technology supports timely clinical decision-making to prevent brain damage from conditions such as cerebral edema and shunt dysfunction. With over 36,000 patients monitored across 186 active accounts, brain4care's platform delivers immediate digital clinical reports derived from proprietary surrogate ICP waveform analysis. The company collaborates with leading research institutions including Stanford University and the University of Cambridge and maintains ongoing clinical evidence publication.

NeuroWave Systems Inc. is a medical device manufacturer specializing in advanced brain monitoring technologies for anesthesia, sedation, and critical care applications. Founded in 2007 as a spin-off from CleveMed, the company develops innovative EEG-based monitoring systems that provide real-time assessment of brain function and anesthetic effect. The flagship NeuroSENSE® Monitor delivers bilateral brain indices, enabling clinicians to detect asymmetries in brain function and optimize patient-specific drug delivery. The company's product portfolio includes the NeuroSENSE OEM Module for third-party integration and specialized electrodes for high-quality signal acquisition. NeuroWave targets operating rooms, ICUs, and anesthesia departments, emphasizing automation in anesthesia protocols to improve patient safety and reduce healthcare costs through precise, data-driven sedation management.

Medical Decision Network (MDN) provides comprehensive healthcare software solutions focused on improving critical care quality and outcomes. The company specializes in ICU performance analytics, glycemic control management, and predictive severity modeling. MDN's flagship products include GlucoStabilizer®, an FDA-cleared IV insulin dosing system that automates glucose management and reduces hypoglycemia risk in hospitalized patients, and MDN PHOENIX, a critical care software platform featuring ACUITY 2019 predictive modeling for severity-adjusted outcome measurement. ACUITY 2019 delivers fully automated severity scoring with observed/expected calculations for length of stay, hospital mortality, and mechanical ventilation duration predictions—eliminating manual data collection while improving upon legacy APACHE models. ICUTracker® provides outcomes reporting and ICU performance benchmarking capabilities. These solutions enable hospitals to optimize clinical workflows, reduce glycemic variability complications, and drive data-driven process improvements across critical care units.

Shenzhen Prunus Medical Co., Ltd. (普博医疗) is a leading Chinese manufacturer of acute and critical care solutions, founded in 2007. The company specializes in mechanical ventilation, perioperative care, and hemodynamic monitoring equipment serving over 1,000 tertiary hospitals and exporting to 100+ countries. Prunus is a national-level "specialized and sophisticated small giant" enterprise with 33% of workforce dedicated to R&D. The product portfolio includes ventilators (Padus series for ICU/transport; Q series for home use; Boaray emergency models), anesthesia machines (Boaray and Pumila lines), infusion pumps (TPC, TMS, TMV series), portable ultrasound systems (iSoniQ80, iSoniQ 30A), critical care consumables (pressure sensors, central venous catheters, thermal dilution catheters, pacing catheters, silicone catheters), medical air compressors, and patient monitors. The company also offers digital health solutions including operating room management systems, ICU monitoring platforms, emergency department systems, telemedicine, and acute critical illness integration platforms. Manufacturing and R&D operations span Shenzhen (headquarters), Weihai, Singapore, Italy, Sweden, and Canada. Prunus holds ISO 13485 certification, multiple NMPA approvals, CE certification, and is a designated WHO supplier. The company functions as an OEM/ODM partner for international ventilator and anesthesia manufacturers.

Solaborate Inc. develops hellocare, an integrated end-to-end telehealth and virtual healthcare delivery platform combining software, hardware, and artificial intelligence. The platform serves hospitals, home care, and primary care settings, enabling clinicians to deliver remote patient care through multiple modalities: virtual patient observation (up to 16 rooms monitored simultaneously), telehealth consultations, remote patient monitoring (RPM), and digital clinic services. Core capabilities include real-time audio/video communication, secure messaging, EHR integration, dynamic workflow management, and AI-driven alerting for fall detection and patient behavior monitoring. The company supplies integrated telemedicine carts (mobile hardware and software solutions), remote examination kits that enable physicians to assess vital signs and conduct clinical examinations from patient homes, and communication tools linking clinicians, nurses, and healthcare teams. The platform processes continuous patient observation data, captures health metrics from connected medical devices, and uses edge-based AI algorithms to generate clinical alerts while maintaining patient privacy. Solaborate maintains HIPAA compliance, HITRUST certification, SOC 2 attestation (AICPA), and CE marking. The platform is used by major healthcare systems including Amwell, Northwell Health, and Swiss healthcare organizations. Intended for B2B deployment in hospital systems, urgent care, home health agencies, and telemedicine networks requiring turnkey virtual care delivery infrastructure.

Cloud DX Inc. is a Canadian healthcare technology company specializing in remote patient monitoring (RPM) hardware, software, and digital health services. The company develops the FDA-registered, Health Canada-licensed Connected Health™ platform, which enables comprehensive vital sign monitoring and clinical engagement for chronic disease management, post-surgical care, palliative care, and transitional care. Cloud DX's integrated solution includes wireless vital sign devices (blood pressure monitors, weight scales, pulse oximeters), a clinician dashboard for real-time patient data review, a mobile app for patient engagement, and telemedicine capabilities powered by Zoom or Teladoc. The platform is currently deployed across 12 clinical use cases including COPD, heart failure, diabetes, post-surgical monitoring, and complex pediatric home care. Cloud DX operates a Virtual Care as a Platform (VCaaP) model with demonstrated patient satisfaction of 89–100% and peer-reviewed clinical evidence of improved outcomes, reduced ER visits, and decreased hospital admissions.

Dräger is a German multinational medical technology and industrial safety company founded in 1889, headquartered in Lübeck. The company is a global leader in critical care, respiratory protection, and safety equipment. Dräger's medical division provides advanced ICU ventilators, anesthesia systems, patient monitoring solutions, and neonatal care equipment for hospitals and intensive care units worldwide. The company pioneered the Roth-Dräger anesthesia apparatus in 1902 and continues to innovate in life support and respiratory technologies. Dräger's safety division manufactures respiratory protective equipment, gas detection systems, and industrial safety products for hazardous environments including mining, oil & gas, and emergency services. With over 10,000 employees across 50+ countries, Dräger operates under its Technology for Life philosophy, focusing on protecting and saving lives through integrated medical and safety solutions for healthcare facilities, industrial operations, and emergency response teams.

Prescott's is a specialty biomedical equipment and depot solutions provider serving healthcare facilities nationwide. The company operates through multiple specialized divisions—each a leader in its category—offering sales, rentals, maintenance, preventive maintenance, repair, and refurbishing services for surgical and clinical equipment. Core product lines include reconditioned surgical microscopes (since 1984), anesthesia equipment and systems, infusion pumps, patient monitors, sterilizers, washers, and auxiliary surgical equipment. Prescott's emphasizes rapid response (guaranteed 24-hour response time), certified biomedical technicians, component exchange warranties, and service-first partnerships. The company acquired Tenacore to expand depot-based repair, parts distribution, and technical support for patient monitoring, surgical, respiratory, and fluid delivery equipment across multiple modalities.

Sentinel Medical Technologies, LLC manufactures the TraumaGuard System, a continuous real-time intra-abdominal pressure (IAP) monitoring device designed for ICU and trauma care settings. The TraumaGuard System addresses a critical clinical gap in the detection and prevention of Intra-Abdominal Hypertension (IAH) and Abdominal Compartment Syndrome (ACS), two major causes of multi-organ failure and death in ICU patients. The device delivers automated, accurate IAP measurements (±3 mmHg accuracy) with the capability to measure in both supine and elevated patient positions. Key features include continuous bedside and nurses' station monitoring with proactive alerts, automatic recording and storage to EMR systems, and prevention-focused early detection of IAP elevations before progression to IAH or ACS. Clinical evidence supports that 3 in 5 ICU patients experience IAP elevations, yet only 31% of physicians routinely measure IAP due to inefficiency and operator-dependence of legacy techniques. The TraumaGuard System is positioned as the first device to establish a new standard of care for IAP measurement in critical care environments. The company targets ICU, trauma, and emergency departments where continuous vital sign monitoring is essential. Regulatory status and specific certifications were not explicitly detailed on the fetched homepage.

Infinium Medical, Inc. is an FDA-registered, ISO 13485:2016-certified manufacturer of patient monitoring systems and critical care equipment headquartered in Largo, Florida. The company manufactures multiparameter patient monitors, capnography/EtCO2 monitors, portable vital signs monitors, anesthesia machines, surgical lighting systems, surgical tables, video laryngoscopes, electrosurgical generators, vein viewers, infusion pumps, patient warming systems, and surgical procedure chairs. Products are designed for use in hospital ICUs, operating rooms, emergency response, surgery centers, and field clinics. The company emphasizes intuitive interface design, reliability, and cost-effectiveness. Manufacturing facilities maintain ISO 13485 quality controls and comply with FDA regulations, EU MDR, and CE 0476 certification. Product lines include the OMNI Express and OMNI III patient monitors, Luxor surgical light series (250, 300, 400), ST500E surgical table (1000 lb capacity), OBA-1 portable anesthesia machine, ClearVue video laryngoscopes, Infinium Edge 200 ESU, and various specialized monitors for capnography and cardiac assessment. The company distributes both manufactured and partner equipment, serving domestic US markets and international customers. Technical support, warranty programs, and after-sales service are provided through their Tampa-area headquarters.

Cables and Sensors, LLC is a specialized distributor of patient monitor accessories and replacement cables serving over 10,000 healthcare facilities. The company supplies SpO2 sensors, ECG/EKG cables, NIBP (noninvasive blood pressure) tubing and accessories, IBP (invasive blood pressure) transducers and cables, temperature probes, fetal monitoring cables, and oxygen sensors compatible with major OEM equipment manufacturers including Philips, GE Marquette, Draeger, Datex Ohmeda, Spacelabs, Nihon Kohden, Zoll, and Masimo. Products are offered as cost-effective alternatives to original equipment manufacturer (OEM) supplies, with reported savings of up to 50% while maintaining warranty coverage meeting or exceeding OEM standards. The company operates a same-day shipping model with 99% same-day fulfillment capability and serves hospitals, clinics, biomedical departments, military facilities, and non-profit organizations. Products are compatible with patient monitors, ventilators, anesthesia machines, and intensive care equipment across acute care, emergency, neonatal, and fetal monitoring applications.

Natus Medical Incorporated is a leading provider of neurodiagnostic and sensory assessment solutions serving hospitals, clinics, and research facilities. The company specializes in electroencephalography (EEG), electromyography (EMG), nerve conduction studies (NCS), and evoked potential (EP) technologies for diagnosing and monitoring brain, nerve, and muscle disorders. Core product portfolio includes the UltraPro S100 EMG/NCS/EP system, NeuroWorks EEG software for routine, ambulatory, and ICU monitoring, and BrainWatch, a wireless point-of-care EEG platform for emergency and intensive care settings. Additionally, Natus operates a separate sensory division (natussensory.com) offering hearing and balance assessment, vision screening, and newborn care solutions. With over 80 years of industry experience, the company delivers integrated hardware, software, and data management platforms alongside comprehensive service, support, and clinical education through Natus Academies. Products are designed with clinician input to streamline workflows in routine EEG, long-term monitoring, ICU applications, and research studies. The organization positions itself as a comprehensive neurodiagnostic partner, supporting screening, diagnosis, treatment, and management of neurological and sensory conditions across care settings.

Branchpoint & Aura Development LLC manufactures the AURA™ Wireless ICP Monitor, an implantable intracranial pressure monitoring system for intensive care and neurocritical care applications. The AURA sensor provides continuous telemetric monitoring of intraparenchymal ICP with full waveform data, transmitting wirelessly to standard bedside monitors without requiring new capital equipment investment. The fully implantable sensor is passively powered, eliminating battery implantation risks while enabling physicians to disconnect the physical tether between patient and monitor, improving patient mobility and reducing infection risk in critical care environments.

Future Medical Services Corp is a medical equipment distributor and supplier based in Doral, Florida, specializing in critical care, surgical, and neonatal equipment. The company supplies a comprehensive range of ICU ventilators (MEK ICU Ventilator), portable respiratory systems, multiparameter patient monitors, infusion pumps, and anesthesia machines. Their neonatal product line includes incubators, transport incubators, infant warmers, and phototherapy systems under the Vitalife brand. Surgical offerings encompass operating tables, LED surgical lights, and electrosurgical units. The company also distributes ECG machines, fetal monitors, hospital beds, and difficult airway intubation devices, along with associated accessories and consumables. Products are marketed primarily to Latin American and Caribbean healthcare facilities. The company emphasizes international logistics capabilities for equipment distribution. While specific FDA clearances or ISO certifications are not detailed on the current site, the product portfolio reflects standard medical device categories subject to regulatory oversight. Future Medical Services functions as both a distributor and, for certain branded lines like Vitalife, an apparent exclusive or preferred vendor for Latin American markets.

Atrility Medical (Madison, WI) develops FDA-cleared cardiac monitoring devices focused on post-operative arrhythmia detection and management. The AtriAmp is a bedside monitoring device that provides continuous atrial electrograms by connecting temporary atrial pacing wires to patient monitors and external pacemakers. It enables real-time visualization of intracardiac atrial signals on standard ICU monitors for both pediatric and adult patients. The device eliminates workflow delays associated with traditional atrial ECG acquisition methods, allowing clinicians to identify arrhythmias earlier, improve diagnostic accuracy, and facilitate timely treatment decisions in post-cardiac surgery settings. The AtriAmp connects to standard patient monitor ECG modules and integrates with major temporary pacemaker platforms from Medtronic, Oscor/Osypka, St. Jude Medical, and Cardiotronic.

Sotera Wireless develops the ViSi Mobile Patient Monitoring System, a comprehensive vital signs monitoring platform designed for continuous, real-time surveillance of patients in general care, acute care, and transport settings. The system utilizes body-worn sensors to provide noninvasive, cuff-less monitoring of blood pressure, oxygen saturation (SpO2), respiration rate, pulse, electrocardiography (ECG), patient posture, and cardiac arrhythmia detection. The platform integrates machine learning algorithms trained on millions of hours of patient data to recognize early signs of patient deterioration, including sepsis and life-threatening events, while minimizing false alarms and alert fatigue. Data streams directly into electronic medical records (EMR) systems, enabling clinicians to detect critical changes between scheduled vital sign checks and respond with rapid intervention. The system is designed for ambulatory patients, those in transport, and bedside monitoring, providing continuous surveillance with enhanced clinical workflow integration. The ViSi Mobile platform emphasizes patient safety through early warning systems that address the clinical gap where dangerous deterioration can occur during intervals between conventional spot-check vital sign assessments.

Masimo Corporation is a global leader in noninvasive patient monitoring solutions, specializing in innovative pulse oximetry, vital sign monitoring, and brain function monitoring technologies. Founded on breakthrough accuracy in pulse oximetry (Masimo SET®), the company develops and manufactures continuous monitoring systems for hospitals, ICUs, operating rooms, and neonatal care settings. Core product lines include Masimo SET® Pulse Oximetry for continuous, accurate oxygen saturation measurement across all patient populations and clinical settings; SedLine® Brain Function Monitoring for depth-of-anesthesia and sedation monitoring; Masimo O3® Regional Oximetry for tissue oxygenation assessment with FDA-cleared hemoglobin parameters; and Root® Patient Monitoring and Connectivity Platform, a modular hospital automation system integrating vital signs, connectivity, and clinical workflow solutions. Masimo technologies are deployed across acute care, perioperative, emergency, neonatal, and general floor environments. The company holds over 900 patents globally and serves leading hospitals and healthcare systems in 30+ countries. Known for motion-artifact rejection and performance accuracy across diverse patient populations, Masimo's solutions address clinical needs in congenital heart disease screening, critical care monitoring, anesthesia management, and cost reduction through early patient distress detection. The company emphasizes sustainability and has strategic partnerships with major healthcare technology providers including Philips. Acquired by Danaher in February 2026.

Potrero Medical develops the Accuryn® Monitoring System, a next-generation smart catheter platform designed for early detection and prediction of acute kidney injury (AKI) in critical care settings. The system transforms a standard Foley catheter into an intelligent device that automates clinical data capture, visualizes kidney function trends, and provides real-time monitoring to enable earlier clinical interventions. The platform integrates with existing hospital workflows to reduce time clinicians spend managing data while increasing time spent with patients. Accuryn targets hospital ICU and acute care environments where AKI is prevalent, including post-sepsis monitoring and intra-abdominal compartment syndrome detection. The company focuses on predictive health capabilities that surface patterns not visible through traditional monitoring, addressing the significant clinical burden of AKI, which affects approximately 47.5% of sepsis patients and results in 300,000 annual US deaths. The system is positioned for use in adult critical care units, particularly in hospitals with high-acuity patient populations requiring intensive hemodynamic and renal function monitoring.

AA Medical, operating as AA Medical Store, is a leading distributor of new and reprocessed medical equipment specializing in the aftermarket medical device resale sector. Founded in 2010 and headquartered in Mokena, Illinois with operations in Miami, Florida, the company supplies a comprehensive range of surgical and diagnostic equipment through an extensive network of 350+ sales representatives and relationships with 2,800+ healthcare facilities. AA Medical offers one of the largest online inventories of minimally invasive surgical equipment, endoscopy systems, orthopedic instrumentation, and surgical visualization technology at competitive, cost-optimized pricing. The company specializes in pre-owned and post-lease equipment across endoscopy, orthopedics, anesthesia, urology, and gynecology, emphasizing sustainable sourcing and white-glove customer service. Key product categories include visualization systems, surgical power instruments, laparoscopy and arthroscopy equipment, orthopedic implants and tools, patient monitoring and care devices, operating room infrastructure, and laboratory equipment from trusted manufacturers including Stryker, Arthrex, Conmed, Olympus, and Karl Storz.

Terumo Cardiovascular Systems Corp. is a leading manufacturer of cardiopulmonary bypass and perfusion equipment, specializing in oxygenators, heart-lung machines, blood gas monitoring systems, and endoscopic vessel harvesting (EVH) products for cardiac surgery. The company manufactures the world's longest-running line of commercially available heart-lung machines and pioneered the first hollow fiber oxygenator technology. Terumo's product portfolio includes advanced perfusion systems, continuous in-line blood gas monitors (CDI Systems), and specialized surgical instruments for coronary artery bypass grafting (CABG) procedures. Their CDI OneView monitoring system provides real-time monitoring of up to 22 vital patient parameters, serving as an industry benchmark for perfusion management. The company serves cardiac operating rooms, perfusion departments, and cardiovascular surgical centers across North America and internationally. Terumo emphasizes quality systems management, clinical outcomes optimization, and training for perfusionists and cardiac surgeons. The company provides educational webinars, expert guidance on EVH techniques, and perfusion management resources to support clinicians at all experience levels.

Medfrend LLC is a Puerto Rico-based medical technology distributor and solutions provider specializing in point-of-care (POC) testing, blood gas analysis, and clinical laboratory instrumentation for healthcare institutions. The company represents and distributes Radiometer blood gas analyzers (gasometry equipment) for critical patient care diagnostics; Cytek full-spectrum flow cytometry systems with up to 40-color panel capability for research and clinical use (RUO and IVD instruments); and emergency biomarker solutions utilizing closed-tube POC systems for rapid clinical decision-making in intensive care settings. Medfrend also offers the AQURE information management system, a software solution that provides centralized data integration and workflow optimization across point-of-care testing devices and laboratory instruments. The company serves healthcare institutions throughout Puerto Rico, St. Kitts and Nevis, and the Caribbean region. Medfrend emphasizes technical expertise, local market knowledge, and ongoing customer support through a team of experienced professionals. The company positions itself as a value-added distributor providing not only equipment but also clinical consulting, workflow optimization, and alignment with emerging healthcare trends in diagnostics and laboratory testing.

ImaCor Inc develops hemodynamic ultrasound systems for critical care settings, with primary focus on transesophageal echocardiography (TEE) for ICU, cardiac surgery, surgical/trauma, and intensive care units. The company's Hemodynamic Ultrasound platform enables direct visualization of cardiac filling and function over time to assess and guide interventions for critically ill patients. Core products include the Zura Handheld device and ClariTEE Probe, deployed via the proprietary hTEE 3-Step Method. This method combines gold-standard transesophageal echo practices with critical care protocols, allowing visualization of transgastric short axis, midesophageal four chamber, and SVC views. Clinical evidence indicates hTEE made direct therapeutic impact in 66% of patients and improved hemodynamics in 80% of cases. Primary clinical applications include fluid management and preload assessment, cardiac surgery support, trauma resuscitation, LVAD (left ventricular assist device) monitoring, and differentiation of cardiac tamponade from other causes of hemodynamic compromise. The company serves surgeons, intensivists, nurse practitioners, and trauma program managers across CVICU, SICU, MICU, and ED settings. ImaCor provides comprehensive educational support including whiteboard lessons, learning modules, case studies, peer-reviewed evidence, and 24/7 technical support. The platform addresses critical gaps in bedside cardiac assessment beyond traditional indirect methods such as blood pressure, lactate, and cardiac output monitoring.

PyrAmes Inc develops innovative non-invasive, continuous blood pressure monitoring solutions for patients across all age groups. The company specializes in wireless, calibration-free platforms designed to eliminate the need for invasive arterial lines and improve BP measurement accuracy in critical care settings. Product platforms include: - Boppli®: FDA 510(k)-cleared continuous non-invasive BP monitoring for neonatal and pediatric patients in NICU/PICU environments. Clinical evidence published in peer-reviewed journal Neonatology demonstrates accuracy comparable to arterial lines with superior usability and safety profile. - Bosimi®: Continuous non-invasive BP monitoring system for adult inpatient and emergency department care, enabling real-time hemodynamic assessment without invasive instrumentation. - Bosimi@Home™: Home-based platform for BP diagnostics, treatment validation, and medical management, supporting chronic disease monitoring and hypertension control in ambulatory settings. PyrAmes addresses significant clinical gaps: over 50% of NICU admissions could benefit from continuous BP monitoring but currently receive only intermittent cuff measurements or invasive arterial lines due to cost and safety concerns. In adults, hypertension affects 50% of the US population and contributes to 7.6 million deaths annually worldwide, creating demand for non-invasive continuous monitoring solutions. The company holds FDA 510(k) clearance for Boppli, FDA Breakthrough Device Designation, and recognition from the American Heart Association and National Institutes of Health (NIH RADx Tech Maternal Health Challenge). PyrAmes is a founding member of the CDC National Hypertension Control Roundtable. The technology enables early detection of hemodynamic instability in vulnerable populations including preterm infants and hypertensive adults.

Caretaker Medical manufactures VitalStream ART, a dual-modality continuous hemodynamic monitoring platform for ICU, operating room, and high-acuity care settings. The device delivers beat-by-beat hemodynamic data through both invasive arterial line connectivity and non-invasive wearable sensors, enabling clinicians to monitor patients from pre-operative assessment through discharge. VitalStream operates as a unified platform compatible with standard arterial lines (no proprietary transducers required) and integrates with GE Carescape and Philips Intellivue monitors. The wearable sensor provides up to 10 days of continuous monitoring without cabling, supporting patient mobility across care phases. Clinical validation includes 20 peer-reviewed studies documenting accuracy in surgical, ICU, and critical care populations. The company reports deployment in 150+ clinical customers across 20+ hospitals. VitalStream is FDA-cleared and CE-marked. Key clinical benefits include early detection of hemodynamic decompensation (cardiac output decline, missed hypotensive events), reduced acute kidney injury and myocardial injury post-surgery, and cost savings up to $300k annually per ICU room versus competing invasive systems. Operational setup requires under 90 seconds with no complex configuration.

SOPHYSA is a French medical device manufacturer with 50 years of expertise in cerebrospinal fluid (CSF) management and neuromonitoring solutions. Headquartered in Orsay, France with manufacturing and R&D in Besançon, the company serves neurosurgery and neurocritical care specialties globally, including a US subsidiary in Crown Point, Indiana. SOPHYSA manufactures implantable and external drainage systems for hydrocephalus management, intracranial pressure (ICP) monitoring devices, and access ports for neurological applications. Core product lines include adjustable CSF shunting valves (Polaris®, Sophy® Mini SM8, Sophy® Mini SM1), anti-siphon devices (SiphonX®), external ventricular drainage systems and catheters, ICP/temperature monitoring catheters (Pressio® line), implantable access ports (Soph-A-Port®), and associated accessories and reservoirs. The Pressio® 2 system provides integrated intracranial pressure and temperature monitoring for critical care settings. All products are designed for MRI compatibility where applicable. The company serves hospitals, neurosurgical centers, and critical care facilities across multiple continents. Manufacturing capabilities include precision medical device fabrication with quality systems and regulatory compliance in multiple markets.

AirLife is a leading North American manufacturer and distributor of consumable medical devices focused on anesthesia and respiratory care. The company manufactures and distributes a comprehensive portfolio of airway management, respiratory support, emergency resuscitation, anesthesia, patient monitoring, and home care products. Key product lines include endotracheal tubes, closed suction systems, humidification devices, sterile water delivery systems, and breathing circuits. The company owns and operates multiple well-established brands including Air-Q®, BALLARD™, Broselow™, Salter Labs®, SunMed®, Westmed®, and Ethox Medical®. AirLife serves acute care hospitals, emergency medical services (EMS), surgical centers, and home care settings across North America. The company has demonstrated growth through strategic acquisitions, including the 2023 acquisition of Avanos Medical's Respiratory Health Business. AirLife products are used in critical care, operating room, emergency department, and out-of-hospital settings. The company maintains manufacturing and distribution capabilities and has announced operational expansion into additional markets. Regulatory credentials and specific certifications are not detailed on the homepage but are typical for medical device manufacturers in this category (FDA 510(k), ISO 13485). AirLife emphasizes quality, innovation, and clinical efficacy in respiratory and anesthesia care delivery.

VirtuSense is a healthcare technology company specializing in spatial artificial intelligence solutions for acute care environments. The company's flagship product, VSTOne®, is a single-source platform designed to bring hospital rooms into the future through autonomous patient monitoring and clinical decision support. VSTOne operates on a 99.99% accuracy rate and integrates with Epic MyChart to assist clinicians and patients. The platform addresses multiple clinical use cases within a single device, including autonomous fall prevention monitoring, pressure injury prevention, patient monitoring with hybrid human/AI capabilities, virtual nursing with ambient listening and automated clinical note capture, in-room patient AI assistance, violent patient alerting, and real-time location services (RTLS) with handwashing compliance tracking. The solution is designed to eliminate never events and simplify hospital workflows by enabling passive monitoring while clinicians focus on active care tasks. VirtuSense serves a diverse continuum of care including health systems, hospitals, primary care, skilled nursing facilities, assisted living, memory care, and therapy providers. The company reports significant clinical and operational impact, including fall prevention, reduction in false alarms, and measurable medical cost savings. VirtuSense serves major healthcare institutions including Cleveland Clinic, NYU Langone Health, UNC Health, and Mercy Health, among others.

Aulisa Medical is a Palo Alto, CA-based medical device company founded in 2012 that develops FDA-cleared, wireless wearable patient monitoring systems for continuous vital sign tracking in clinical and home environments. The company specializes in cloud-based remote monitoring solutions utilizing artificial intelligence to detect inconsistencies in vital sign data and enable early intervention for potentially adverse events. Products are designed for infants, children, and adults across multiple care settings. The Guardian Angel® product line serves as the primary offering, functioning as both a consumer baby monitor and clinical-grade vital sign monitoring device. Applications include monitoring for sleep safety, chronic respiratory diseases (COPD, sleep apnea), cardiac conditions, post-procedure recovery, and aging-in-place scenarios. The company addresses the need to reduce manual vital sign spot-checking burden for both clinicians and caregivers through automated, continuous monitoring with alert capabilities. Aulisa has achieved FDA clearance for its devices and is backed by Silicon Valley venture capital investors. The company operates both direct-to-consumer and hospital/clinical distribution channels, with products available for in-home use and institutional hospital settings.

Ceribell develops point-of-care EEG systems for rapid seizure detection and monitoring in critical care settings. The company's flagship product, a portable EEG platform integrated with the CLARITY® AI algorithm, enables bedside detection of seizure activity, including non-convulsive seizures, in ICUs, emergency departments, and neurology units. CLARITY® is FDA-cleared for pediatric and neonatal patients, representing the first and only FDA-cleared seizure detection algorithm for newborns preterm and up. The system delivers 95% sensitivity and 97% specificity for status epilepticus detection with 99.9% negative predictive value. Ceribell's secure cloud portal features FedRAMP High cybersecurity authorization for telemedicine consultation and remote EEG interpretation. Clinical evidence demonstrates the platform is associated with 4.1-day shorter median ICU stays and improved neurological outcomes compared to conventional EEG workflows. The company supports hospitals with ongoing in-person and virtual training. Target markets include intensive care units, emergency departments, and neurology departments in acute-care hospitals. Ceribell holds multiple FDA clearances (510(k)), CE mark certification, and has published 45+ peer-reviewed publications validating diagnostic accuracy and clinical utility in critical care populations.

Baxter Healthcare Corporation is a global medical device and pharmaceutical company serving hospitals, physician offices, and home care settings. The company manufactures and distributes essential solutions across primary care, hospital care, surgical care, nutritional care, and respiratory care. Baxter's portfolio includes infusion pumps and IV delivery systems (notably used in chemotherapy and critical care), cardiac monitoring and vital signs equipment, ventilators and oxygen therapy devices, nutritional support products, and vision screening systems. The company emphasizes connected care and digital health integration, addressing the fragmentation of isolated medical devices through data connectivity and clinical workflow optimization. Baxter serves inpatient acute care, intensive care units, operating rooms, outpatient clinics, and home healthcare environments. The company has over 90 years of operational history and maintains substantial manufacturing and supply chain capabilities. Products are designed for use by nurses, physicians, and other clinical staff in hospitals, ICUs, surgical suites, and residential settings. Baxter's regulatory footprint includes FDA-cleared and internationally approved devices. The organization operates under a mission framework emphasizing patient safety, clinical efficiency, and care outcomes improvement.

VitalGo Inc. is a medical equipment manufacturer specializing in the Total Lift Bed (TLB), a motorized ICU bed platform engineered for Intermittent Verticalization Therapy (IVT). The Total Lift Bed is designed for high-acuity patient populations including ECMO, transplant, burn, ARDS, and neurocritical care units. The flagship V5 model features integrated patient scale, low-air-loss mattress, bed exit alerts, and full ICU functionality. The bed enables early mobilization and verticalization of critically ill patients, improving pulmonary outcomes, reducing length of stay, and supporting cardiac stability during recovery. Distributed globally through partners including Agiliti, Arjo, Paramount Beds, and USME, with availability for purchase and daily rental ($150/day) across all U.S. states and 40+ countries. The platform is increasingly adopted as a standard-of-care bed in prestigious teaching hospitals and level-1 trauma centers.

LINET Americas is the North American subsidiary of LINET Group SE, a global leader in advanced hospital bed manufacturing and design. Established in 2010 and headquartered in Charlotte, North Carolina, the company specializes in innovative patient care solutions for acute and post-acute care facilities. With over 1.2 million advanced care beds installed worldwide and production capacity exceeding 130,000 bed frames annually, LINET Americas serves customers across more than 120 countries. The company's comprehensive portfolio includes hospital beds, stretchers, support surfaces, birthing beds, pediatric beds, and integrated care furniture designed for ICU, general ward, and specialty care environments. Beyond manufacturing, LINET Americas provides extensive after-sales services, financing options, and rental programs to ensure optimal equipment operation and maintenance across healthcare facilities.

Retia Medical Systems develops cardiovascular surveillance software and hemodynamic monitoring solutions for intensive care, operating rooms, and perioperative environments. The company's core offering is the Argos® Cardiac Output Monitor, a bedside hemodynamic monitoring device that derives reliable cardiac output and cardiovascular insight from routine physiologic signals without requiring proprietary disposable sensors. The Argos Infinity™ platform extends this capability enterprise-wide, deploying the company's Multi-Beat Analysis (MBA) algorithm across hospital systems and tele-ICU environments to enable centralized cardiovascular surveillance and analytics. Retia's technology is designed to detect hemodynamic instability earlier than traditional vital sign monitoring, particularly in complex scenarios including arrhythmia, cardiogenic shock, low-flow states, and unstable blood pressure. The software integrates with existing monitoring and tele-ICU platforms, transforming real-time physiologic data into actionable clinical intelligence. Deployed in 75+ hospitals including major academic medical centers (Johns Hopkins, Duke Health, Cleveland Clinic, University Hospitals Cleveland, Texas Health Resources, UMC Health System, Rabin Medical Center), the solution has been validated in 14 peer-reviewed clinical studies. Retia received FDA 510(k) clearance for Argos Infinity. The company targets high-risk populations including cardiac and vascular surgery, sepsis, transplant, trauma, burns, and neurocritical care. Primary value propositions include elimination of disposable sensor costs, intuitive bedside workflow design, and system-wide scalability without infrastructure burden.

Ascom Holding AG is a Swiss-based global provider of integrated communication and collaboration solutions for healthcare, long-term care, and enterprise sectors. The company specializes in bridging digital information gaps with mission-critical, near real-time workflow solutions designed for highly mobile, time-sensitive clinical environments. Core offerings include nurse call systems, clinical alarm management, mobile devices (VoWiFi, IP-DECT), staff safety systems, activity monitoring, and IoT-enabled technical alarm integration platforms. Ascom's solutions support clinical surveillance, rapid response team coordination, and workplace safety across acute care hospitals, long-term care facilities, and industrial settings. The company operates subsidiaries in 19 countries and processes 1.3 million data points daily through its systems, enabling healthcare organizations to optimize operational efficiency, reduce alarm fatigue, and enhance patient and staff safety through interoperable, open-source compatible integrations.

Med One Group is a leading independent medical equipment leasing, rental, and sales company headquartered in Sandy, Utah, with nationwide operations since 1991. The company has completed over one billion dollars in lease transactions and operates distribution sites across California, Utah, Georgia, Colorado, Arizona, and Florida. Med One specializes in critical care medical equipment including infusion pumps (BD Alaris systems), ventilators, patient monitors, support surfaces, and hospital beds sourced from leading manufacturers such as BD, Baxter, and Hamilton. The company offers flexible acquisition solutions including capital leases, operating leases, equity rentals, deferred payments, and step-up payment arrangements tailored to hospital and acute care facility requirements. All equipment is delivered patient-ready and backed by comprehensive biomedical services including testing, maintenance, calibration, and the proprietary Asset Refresh Program. Med One's business model emphasizes transparency, competitive pricing, simple lease documentation without hidden fees, and responsive customer service to healthcare facilities nationwide.

Cognito Health is a medical device manufacturer specializing in predictive, contact-free continuous patient monitoring systems for healthcare facilities. Founded in 2012 by physicians and engineers from MIT, Harvard, Stanford, and Taiwan, the company develops AI-powered patient safety solutions designed to reduce hospital-acquired conditions including falls, pressure injuries, and unassisted bed exits. The Cognito Health platform integrates sensor technology with predictive analytics to provide caregivers with actionable, real-time alerts before adverse events occur. Clinical evidence demonstrates up to 43% reduction in patient falls, 71% reduction in pressure injuries, and 92% improvement in nursing efficiency. The scalable solution can be deployed across single units or entire healthcare facilities, supporting acute care, post-acute care, and long-term care settings. The company addresses a significant market need, as falls alone cost U.S. healthcare systems over $50 billion annually. Cognito Health operates globally with offices in the United States and Taiwan, serving hospital systems, rehabilitation centers, and specialized care providers seeking data-driven approaches to patient safety compliance and operational efficiency.

Criticare Technologies, Inc. (CTI) is an international medical device manufacturer founded in 1984, headquartered in Warwick, Rhode Island. CTI specializes in patient monitoring devices and anesthetic gas monitoring systems designed for critical care, anesthesia, respiratory care, transport, and outpatient environments. The company's product portfolio combines technological innovation with cost-effective design to address patient safety and continuous monitoring requirements across acute and perioperative settings. CTI provides comprehensive technical support, equipment servicing, and rental-ownership programs to ensure affordability and consistent operational reliability for healthcare facilities.

Bio Medical Equipment Service Company (BMES) is a Louisville-based depot repair specialist focused on patient monitoring and telemetry equipment repair since 1989. BMES provides nationwide repair services for patient monitors, telemetry transmitters, infusion pumps, bedside modules, fetal transducers, oxygen blenders, and suction regulators. The company operates a centralized repair facility in Louisville, strategically positioned minutes from the UPS Worldport hub to enable rapid turnaround. Services include flat-rate depot repair with 3–5 day turnaround, a 6-month Confident Care Warranty, and a 7-step critical care process ensuring all equipment returns to OEM specifications. BMES also offers refurbished equipment sales and rentals, and partners with BC Group for biomedical test equipment provision. The company works with major OEM brands including Philips, CareFusion, Spacelabs, Welch Allyn, Sechrist, and Nihon Kohden. Repair services are non-RMA-based, with free shipping label provision and dedicated account representative support. Facilities inspection and testing verify patient readiness prior to shipment. Primary markets served include hospitals, surgical centers, and healthcare networks across the United States. No specific FDA or ISO certifications are detailed on the site, though quality processes and warranty backing suggest compliance with medical device repair standards.

Redsense Medical develops and manufactures patented fiber optic blood leak detection systems designed for hemodialysis access monitoring. The company's core offering detects venous needle dislodgement and central catheter leakage through innovative fiber optic sensor technology, triggering immediate alarms to prevent blood loss. The system is available in two configurations: venous fistula and central catheter solutions. Redsense devices are FDA-cleared and CE-marked for use across all dialysis modalities. The alarm unit integrates with IEC PAS 63023-compliant dialysis machines, enabling automatic blood flow stoppage when leakage is detected. The technology addresses a critical patient safety gap in hemodialysis by enabling rapid detection and response to access complications. Redsense operates across Europe and North America with a focus on dialysis provider deployment.

Mindray is a leading global medical device manufacturer headquartered in Shenzhen, China, founded in 1991. The company designs, manufactures, and distributes a comprehensive portfolio of medical devices and healthcare solutions across three primary segments: Patient Monitoring & Life Support, In-Vitro Diagnostics, and Medical Imaging Systems. With operations spanning 60 international subsidiaries across more than 30 countries and an employee base exceeding 18,000, Mindray serves healthcare facilities in over 190 countries. The company invests approximately 10% of annual revenue in research and development. Current product offerings include the TE X and TE Air portable ultrasound systems for point-of-care imaging, the Resona A20 premium ultrasound platform with Acoustic Intelligence Technology, BeneVision N-Series patient monitors for high-acuity care, SV900/SV700 ventilators for respiratory support across all patient ages, and A8/A9 Anesthesia Workstations. Mindray also manufactures surgical tables and vital signs monitoring equipment. The company emphasizes innovation, quality, and accessibility in healthcare technology.

ANESTHESIA EQUIPMENT SUPPLY, INC. (AES, Inc.) is a premier provider of anesthesia equipment, patient monitoring solutions, and related healthcare supplies serving operating rooms, ICUs, and veterinary facilities. The company specializes in new and used anesthesia machines, custom anesthesia accessories, laryngeal mask airways, video laryngoscopes, nerve stimulators, and patient safety equipment. AES offers comprehensive product support including anesthesia machine servicing, trace gas testing, machine verification, and custom component design. Their product portfolio extends to ultrasound systems, perfusion accessories, CO2 absorbents, vaporizers, and Mindray-branded patient monitoring equipment. AES maintains expertise in both human and veterinary anesthesia applications, providing innovative solutions at competitive pricing with emphasis on customer satisfaction and clinical safety.

CONMED Corporation is a global medical technology company specializing in the design, manufacture, and distribution of surgical devices and patient care solutions. Founded in 1970, the company serves hospitals, ambulatory surgery centers, and physician offices worldwide with a comprehensive portfolio focused on orthopedic and general surgical specialties, plus patient monitoring systems. Core product lines include arthroscopy instruments, electrosurgical generators, insufflation systems (AirSeal®), surgical power tools, smoke evacuation systems, soft tissue implants (BioBrace®), suture anchors, and advanced surgical imaging systems. CONMED emphasizes clinical innovation and user experience, collaborating with medical professionals to deliver reliable solutions that enhance surgical outcomes and recovery while maintaining commitment to quality and customer-centric service.